Home
Conditions
Blood Protein Disorders

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,041 public trials 566 recruiting studies

Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Completed

Cancer Stem Cells in Multiple Myeloma

NCT01820546

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Ankara University Hematology Unit Ankara, Turkey (Türkiye)

View Trial Details

Completed

Safety and Dose Study of GRN163L Administered to Treat Patients With Refractory or Relapsed Multiple Myeloma

NCT00594126

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Baltimore, Maryland, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Safety and Dose Study of GRN163L and Velcade to Treat Patients With Refractory or Relapsed Myeloma

NCT00718601

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: Karmanos Cancer Center Detroit, Michigan, United States

St. Vincent's Comprehensive Cancer Center New York, United States

Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies

NCT00002818

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +51 more
Locations: Massey Cancer Center Richmond, Virginia, United States

View Trial Details

Completed

A Study of Tanespimycin (KOS-953) in Patients With Relapsed-refractory Multiple Myeloma

NCT00514371

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Local Institution Berkeley, California, United States

Local Institution San Francisco, California, United States

Local Institution Augusta, Georgia, United States

Local Institution Baltimore, Maryland, United States

View Trial Details

Completed

Temsirolimus and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma

NCT00693433

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Veteran's Administration Medical Center Las Angeles, California, United States

View Trial Details

Completed

UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy

NCT00083551

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States

View Trial Details

Completed

Geriatric Assessments in Senior Adults With Multiple Myeloma

NCT01746030

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

B-Receptor Signaling in Cardiomyopathy

NCT01135849

Conditions: Adenocarcinoma, Adenoma, Amyloidosis, +140 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

C11-Acetate PET/CT in Multiple Myeloma: Added Value to F18-Fluorodeoxyglucose PET/CT

NCT01691300

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Chang Gung Memorial Hostpial Guishan, Taoyuan county, Taiwan

View Trial Details

Blood Protein Disorders

Blood Protein Disorders trial results

Related conditions